gold has been researched along with vitamin k semiquinone radical in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kimur, I; Saito, K; Sato, S; Takahashi, K; Tanizaki, Y | 1 |
| NOFERI, G; PASCUCCI, F | 1 |
| Bandorski, D; Bogossian, H; Hoeltgen, R; Wieczorek, M | 1 |
1 trial(s) available for gold and vitamin k semiquinone radical
| Article | Year |
|---|---|
Menaquinone (vitamin K2) therapy for bronchial asthma. II. Clinical effect of menaquinone on bronchial asthma.
Topics: Asthma; Azathioprine; Clinical Trials as Topic; Desensitization, Immunologic; Drug Combinations; gamma-Globulins; Gold; Histamine; Humans; Mercaptopurine; Placebos; Vitamin K | 1975 |
2 other study(ies) available for gold and vitamin k semiquinone radical
| Article | Year |
|---|---|
Anti-rheumatic therapy and devitaminizing action of drugs; Action of auric salts on the ascorbic acid content of various parenchymes and influence of vitamin C on the onset of tissue lesions caused by these drugs.
Topics: Ascorbic Acid; Drug-Related Side Effects and Adverse Reactions; Gold; Rheumatic Diseases; Vitamin A; Vitamin K; Vitamins | 1945 |
Uninterrupted use of direct oral anticoagulants versus vitamin K antagonists for catheter ablation of atrial fibrillation with PVAC gold: incidence of silent cerebral microembolic events.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Female; Gold; Humans; Incidence; Male; Treatment Outcome; Vitamin K | 2021 |